Sylvester radiation oncology team with colleagues in the Dominican Republic.

Sylvester Radiation Oncologists Travel to Dominican Republic for Consulting Engagement

A group of radiation oncologists from Sylvester Comprehensive Cancer Center recently traveled to the Dominican Republic for a hands-on consulting engagement at Instituto Oncologico Heriberto Pieter in Santo Domingo. The cancer specialists made the trip to as part of the memorandum of understanding signed a year ago with the institute’s medical director, Jose Ramirez, M.D.

Read more »

Miller School of Medicine Rises in NIH Research Grant Funding

The Miller School of Medicine received $120.7 million in research grants from the National Institutes of Health in Federal Fiscal Year 2017 — a $9.5 million increase over the school’s FFY 2016 total. According to the national rankings of medical schools based on data compiled by the Blue Ridge Institute for Medical Research, that total made the Miller School the No. 1 NIH-funded institution in Florida.

Read more »

Erin N. Kobetz, Ph.D., M.P.H., Jimmy Patronis, and Stephen D. Nimer, M.D. (from left in center), with fire department representatives.

Florida CFO Jimmy Patronis Tours Sylvester, Praises Firefighters Cancer Initiative

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine welcomed the State of Florida’s Chief Financial Officer, Jimmy Patronis, on February 5, giving him a tour of its cancer-fighting technologies. Patronis also met with representatives from more than a dozen of South Florida’s fire departments whose members are collaborating with Sylvester’s Firefighters Cancer Initiative.

Read more »

Medical campus update: Hurricane Irma

The latest on Hurricane Irma and how it is affecting the medical campus.

Read more »

Aaron H. Wolfson, M.D.

Sylvester Researchers Show Tumor Size Can Predict Vaginal Cancer Survival

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that tumor size in women with stage I or II vaginal cancer can strongly influence their overall survival. The research was published in the journal Gynecologic Oncology.

Read more »